Cypress Capital Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.8M | Sell |
36,592
-583
| -2% | -$173K | 1.22% | 23 |
|
|
2025
Q4 | $10.2M | Buy |
37,175
+1,536
| +4% | +$417K | 1.14% | 24 |
|
|
2025
Q3 | $9.63M | Buy |
35,639
+777
| +2% | +$211K | 1.15% | 24 |
|
|
2025
Q2 | $9.61M | Buy |
34,862
+726
| +2% | +$197K | 1.2% | 22 |
|
|
2025
Q1 | $9.06M | Buy |
34,136
+120
| +0.4% | +$29.6K | 1.19% | 22 |
|
|
2024
Q4 | $7.9M | Sell |
34,016
-174
| -0.5% | -$40K | 0.97% | 25 |
|
|
2024
Q3 | $7.54M | Buy |
34,190
+373
| +1% | +$77.2K | 0.85% | 29 |
|
|
2024
Q2 | $6.65M | Sell |
33,817
-162
| -0.5% | -$33.5K | 0.8% | 32 |
|
|
2024
Q1 | $7.32M | Sell |
33,979
-1,729
| -5% | -$363K | 0.88% | 27 |
|
|
2023
Q4 | $7.52M | Buy |
35,708
+313
| +0.9% | +$66.8K | 0.98% | 25 |
|
|
2023
Q3 | $7.09M | Buy |
35,395
+172
| +0.5% | +$34.2K | 1.02% | 24 |
|
|
2023
Q2 | $6.53M | Sell |
35,223
-819
| -2% | -$151K | 0.94% | 26 |
|
|
2023
Q1 | $6.9M | Sell |
36,042
-4,796
| -12% | -$867K | 1.06% | 22 |
|
|
2022
Q4 | $6.87M | Sell |
40,838
-1,670
| -4% | -$290K | 1.04% | 24 |
|
|
2022
Q3 | $7.53M | Sell |
42,508
-3,509
| -8% | -$693K | 1.26% | 17 |
|
|
2022
Q2 | $9.42M | Sell |
46,017
-3,039
| -6% | -$644K | 1.43% | 11 |
|
|
2022
Q1 | $11.7M | Buy |
49,056
+428
| +0.9% | +$101K | 1.44% | 13 |
|
|
2021
Q4 | $11.1M | Sell |
48,628
-3,036
| -6% | -$668K | 1.39% | 16 |
|
|
2021
Q3 | $9.99M | Buy |
51,664
+228
| +0.4% | +$46.2K | 1.36% | 16 |
|
|
2021
Q2 | $10.9M | Buy |
51,436
+832
| +2% | +$176K | 1.48% | 16 |
|
|
2021
Q1 | $10.3M | Sell |
50,604
-822
| -2% | -$162K | 1.47% | 15 |
|
|
2020
Q4 | $9.36M | Sell |
51,426
-1,058
| -2% | -$180K | 1.41% | 18 |
|
|
2020
Q3 | $8.78M | Sell |
52,484
-5,788
| -10% | -$975K | 1.46% | 16 |
|
|
2020
Q2 | $9.47M | Sell |
58,272
-1,530
| -3% | -$274K | 1.74% | 12 |
|
|
2020
Q1 | $10.3M | Sell |
59,802
-2,706
| -4% | -$539K | 2.39% | 7 |
|
|
2019
Q4 | $12.5M | Buy |
62,508
+622
| +1% | +$128K | 2.23% | 5 |
|
|
2019
Q3 | $13.1M | Sell |
61,886
-988
| -2% | -$206K | 2.52% | 4 |
|
|
2019
Q2 | $12.2M | Buy |
62,874
+325
| +0.5% | +$59.9K | 2.41% | 4 |
|
|
2019
Q1 | $10.3M | Sell |
62,549
-396
| -0.6% | -$70K | 2.11% | 7 |
|
|
2018
Q4 | $11.8M | Sell |
62,945
-633
| -1% | -$117K | 2.71% | 4 |
|
|
2018
Q3 | $10.8M | Buy |
63,578
+684
| +1% | +$115K | 2.05% | 6 |
|
|
2018
Q2 | $10.3M | Sell |
62,894
-163
| -0.3% | -$26.6K | 2.13% | 6 |
|
|
2018
Q1 | $10.2M | Sell |
63,057
-105
| -0.2% | -$16.7K | 2.14% | 7 |
|
|
2017
Q4 | $9.22M | Sell |
63,162
-945
| -1% | -$135K | 1.92% | 7 |
|
|
2017
Q3 | $8.7M | Buy |
64,107
+645
| +1% | +$81.5K | 1.85% | 8 |
|
|
2017
Q2 | $7.95M | Sell |
63,462
-1,234
| -2% | -$148K | 1.76% | 12 |
|
|
2017
Q1 | $7.69M | Sell |
64,696
-1,423
| -2% | -$171K | 1.8% | 13 |
|
|
2016
Q4 | $7.63M | Sell |
66,119
-695
| -1% | -$77.3K | 1.81% | 14 |
|
|
2016
Q3 | $6.98M | Buy |
66,814
+265
| +0.4% | +$27.7K | 1.67% | 17 |
|
|
2016
Q2 | $6.48M | Buy |
66,549
+771
| +1% | +$72.9K | 1.52% | 21 |
|
|
2016
Q1 | $6.32M | Buy |
65,778
+688
| +1% | +$62.6K | 1.55% | 19 |
|
|
2015
Q4 | $5.9M | Buy |
65,090
+877
| +1% | +$82.5K | 1.42% | 22 |
|
|
2015
Q3 | $5.96M | Sell |
64,213
-395
| -0.6% | -$37.5K | 1.47% | 21 |
|
|
2015
Q2 | $6.01M | Buy |
64,608
+1,540
| +2% | +$144K | 1.38% | 26 |
|
|
2015
Q1 | $5.97M | Buy |
63,068
+16,440
| +35% | +$1.52M | 1.36% | 24 |
|
|
2014
Q4 | $4.13M | Buy |
46,628
+7,271
| +18% | +$616K | 0.96% | 38 |
|
|
2014
Q3 | $3.15M | Buy |
39,357
+4,212
| +12% | +$317K | 0.75% | 48 |
|
|
2014
Q2 | $2.49M | Buy |
+35,145
| New | +$2.47M | 0.58% | 59 |
|
Other funds holding CME
VCM
VPM
Cypress Capital Group's CME Position: Q1 2026 in Review
Cypress Capital Group reduced its CME Group (CME) stake by 1.6% in Q1 2026, selling an estimated $173K and leaving 36,592 shares worth $10.8M. The position accounts for 1.22% of the portfolio, ranked #23.
Cypress Capital Group first reported a position in CME in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.1M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Cypress Capital Group held 36,592 shares of CME Group worth $10.8M as of Q1 2026.
- Cypress Capital Group sold 583 CME Group shares in Q1 2026, an estimated $173K.
- CME Group made up 1.22% of Cypress Capital Group's portfolio in Q1 2026, its #23 holding.
- Cypress Capital Group first reported a position in CME Group in Q2 2014 and has held it in 48 quarters since.
- Cypress Capital Group's CME Group position peaked at $13.1M in Q3 2019.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.